Literature DB >> 7165382

Decline of plasma concentrations of etretinate and its main metabolite after treatment.

J Lauharanta, U Paravicini, L Kanerva, A Lassus.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7165382     DOI： 10.1007/bf00403745

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN： 0340-3696            Impact factor:   3.017


× No keyword cloud information.
  5 in total

1.  [The metabolism of the retinoid Ro 10-9359. Isolation and identification of the major metabolites in human plasma, urine and feces. Synthesis of three urinary metabolites (author's transl)].

Authors:  R Hänni; F Bigler; W Vetter; G Englert; P Loeliger
Journal:  Helv Chim Acta       Date:  1977-11-02       Impact factor: 2.164

2.  Determination of etretinate and its main metabolite in human plasma using normal-phase high-performance liquid chromatography.

Authors:  U Paravicini; A Busslinger
Journal:  J Chromatogr       Date:  1983-09-09

3.  Plasma and suction blister fluid levels of etretinate and its main metabolite during treatment of psoriasis.

Authors:  J Lauharanta; U Paravicini
Journal:  Arch Dermatol Res       Date:  1982       Impact factor: 3.017

4.  Clinical, ultrastructural and biochemical effects of an aromatic retinoid (etretinate) on psoriasis and Darier's disease.

Authors:  J Lauharanta
Journal:  Acta Derm Venereol Suppl (Stockh)       Date:  1982

5.  On metabolism and pharmacokinetics of an aromatic retinoid.

Authors:  U Paravicini; K Stöckel; P J MacNamara; R Hänni; A Busslinger
Journal:  Ann N Y Acad Sci       Date:  1981-02-27       Impact factor: 5.691
  5 in total
  1 in total

Review 1.  Clinical pharmacokinetics of the retinoids.

Authors:  R W Lucek; W A Colburn
Journal:  Clin Pharmacokinet       Date:  1985 Jan-Feb       Impact factor: 6.447
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.